An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. This has been shown by a new study led by researchers at Linköping University. The scientists hope that the method can eventually be applied within precision medicine and individualised treatment.
It’s common when using social media that the platform suggests people whom you may want to add as friends. The suggestion is based on you and the other person having common contacts, which indicates that you may know each other. In a similar manner, scientists are creating maps of biological networks based on how different proteins or genes interact with each other. The researchers behind a new study have used artificial intelligence, AI, to investigate whether it is possible to discover biological networks using deep learning, in which entities known as “artificial neural networks” are trained by experimental data. Since artificial neural networks are excellent at learning how to find patterns in enormous amounts of complex data, they are used in applications such as image recognition. However, this machine learning method has until now seldom been used in biological research.
“We have for the first time used deep learning to find disease-related genes. This is a very powerful method in the analysis of huge amounts of biological information, or ‘big data’”, says Sanjiv Dwivedi, postdoc in the Department of Physics, Chemistry and Biology (IFM) at Linköping University.
The scientists used a large database with information about the expression patterns of 20,000 genes in a large number of people. The information was “unsorted”, in the sense that the researchers did not give the artificial neural network information about which gene expression patterns were from people with diseases, and which were from healthy people. The AI model was then trained to find patterns of gene expression.
One of the challenges of machine learning is that it is not possible to see exactly how an artificial neural network solves a task. AI is sometimes described as a “black box” – we see only the information that we put into the box and the result that it produces. We cannot see the steps between. Artificial neural networks consist of several layers in which information is mathematically processed. The network comprises an input layer and an output layer that delivers the result of the information processing carried out by the system. Between these two layers are several hidden layers in which calculations are carried out. When the scientists had trained the artificial neural network, they wondered whether it was possible to, in a manner of speaking, lift the lid of the black box and understand how it works. Are the designs of the neural network and the familiar biological networks similar?
“When we analysed our neural network, it turned out that the first hidden layer represented to a large extent interactions between various proteins. Deeper in the model, in contrast, on the third level, we found groups of different cell types. It’s extremely interesting that this type of biologically relevant grouping is automatically produced, given that our network has started from unclassified gene expression data”, says Mika Gustafsson, senior lecturer at IFM and leader of the study in Nature Communications.
The scientists then investigated whether their model of gene expression could be used to determine which gene expression patterns are associated with disease and which is normal. They confirmed that the model finds relevant patterns that agree well with biological mechanisms in the body. Since the model has been trained using unclassified data, it is possible that the artificial neural network has found totally new patterns. The researchers plan now to investigate whether such, previously unknown patterns, are relevant from a biological perspective.
“We believe that the key to progress in the field is to understand the neural network. This can teach us new things about biological contexts, such as diseases in which many factors interact. And we believe that our method gives models that are easier to generalise and that can be used for many different types of biological information”, says Mika Gustafsson.
Mika Gustafsson hopes that close collaboration with medical researchers will enable him to apply the method developed in the study in precision medicine. It may be possible, for example, to determine which groups of patients should receive a certain type of medicine, or identify the patients who are most severely affected.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Study ties blood type to COVID-19 risk: O may help, A may hurton June 19, 2020 at 4:22 pm
LOS ANGELES - A genetic analysis of COVID-19 patients suggests that blood type might influence whether someone develops severe disease. Scientists who compared the genes of thousands of patients in ...
- Alzheimer’s disease-related dysregulation of mRNA translation causes key pathological features with ageingon June 16, 2020 at 12:43 pm
Alzheimer’s disease (AD) is characterised by Aβ and tau pathology as well as synaptic degeneration, which correlates best with cognitive impairment. Previous work suggested that this pathological ...
- PMN.TO: Vectorized Antibodies: Cutting Edge Neurodegenerative Therapyon June 16, 2020 at 12:30 pm
ARFXF Neurodegenerative diseases continue to afflict millions of people worldwide and effective therapies have remained elusive. The best known, most prevalent neurodegenerative pathosis is ...
- Retroviral Vectors for Gene Therapyon June 15, 2020 at 5:00 pm
Lentiviral self-inactivating vectors are the retroviral vectors with the greatest potential for gene therapy Nondividing cells can be transduced by lentiviral vectors. They possess a low ...
- New Data Show Near Elimination of Sickle Cell Disease-Related Vaso-Occlusive Crises and Acute Chest Syndrome ...on June 12, 2020 at 2:51 am
bluebird bio, Inc. (Nasdaq: BLUE) announced that new data from its ongoing Phase 1/2 HGB-206 study of investigational LentiGlobin™ gene therapy for adult and adolescent patients with sickle cell ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Microsoft Azure and Johns Hopkins Medicine have partnered to accelerate precision medicineon June 23, 2020 at 6:31 am
Microsoft Azure and Johns Hopkins Medicine partnered to leverage Microsoft's AI and analytics tools to facilitate precision medicine breakthroughs.
- Assessment of COVID-19's Effect on Precision Medicine Software Market 2020-2024 | Benefits of Precision Medicine to Augment Growth | Technavioon June 22, 2020 at 1:15 pm
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report The ...
- New class of precision medicine strips cancer of its DNA defenseson June 22, 2020 at 1:02 pm
A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class.
- Roadmap for precision medicine in diabetes careon June 22, 2020 at 10:06 am
A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The ...
- Global Precision Medicine Market 2020 Analysis by Manufacturers, End-User, Type, Application, Regions and Forecast to 2026on June 21, 2020 at 8:54 pm
The purpose of this latest market research study titled Global Precision Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 is to provide a comprehensive and ...